Exforge Tablet 10mg/160mg
Product details
Registration number: SIN13418P
Classification: Prescription Only
Active ingredients:
- Amlodipine besylate 13.87mg (corresponds to amlodipine base)
- Valsartan
Strength:
- 10.0mg
- 160.0mg
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: NOVARTIS (SINGAPORE) PTE LTD
ATC code: Not recorded in this imported record.
HSA approval date: 28 February 2008
Manufacturer(s):
- Siegfried Barbera S.L.
- Novartis Farma S.p.A.
Manufacturing country/countries: SPAIN; ITALY
What are the HSA registration number and classification for Exforge Tablet 10mg/160mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13418P
Classification: Prescription Only
What active ingredients and strength are recorded for Exforge Tablet 10mg/160mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Amlodipine besylate 13.87mg (corresponds to amlodipine base)
- Valsartan
Strength:
- 10.0mg
- 160.0mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Exforge Tablet 10mg/160mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for Exforge Tablet 10mg/160mg?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for Exforge Tablet 10mg/160mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Siegfried Barbera S.L.
- Novartis Farma S.p.A.
Manufacturing country/countries: SPAIN; ITALY
Where can I look up Exforge Tablet 10mg/160mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13418P or the exact product name Exforge Tablet 10mg/160mg. The general register link does not preselect this product.
What are the source dates for this Exforge Tablet 10mg/160mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Exforge Tablet 10mg/160mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13418P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)